CVSI - CV Sciences, Inc.
| Previous Close | 4.9600 |
| Open | 4.9900 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 4.8000 - 5.0900 |
| 52 Week Range | 0.3700 - 9.2000 |
| Volume | 529,206 |
| Avg. Volume | 1,138,836 |
| Market Cap | 474.648M |
| Beta (3Y Monthly) | 1.07 |
| PE Ratio (TTM) | 72.21 |
| EPS (TTM) | 0.07 |
| Earnings Date | Mar 27, 2019 - Apr 1, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.00 |
- ACCESSWIRE•3 days ago
4 Marijuana Stocks Bubbling with Excitement on Wednesday (2/13/19)
For the future of the industry to be secured, lawmakers need to press onward with passing this type of legislation, because, ultimately, this will allow companies in the sector to continue operating and developing novel products to distribute throughout the domestic cannabis market, rather than in a select few states. Nabis Holdings (INNPF) (NAB), Canopy Growth Corp (CGC) (WEED), GW Pharmaceuticals plc (GWPH), and CV Sciences Inc (CVSI) are four cannabis companies worth keeping on your radar. Nabis Holdings (INNPF) (NAB) is a Canadian investment company determined to make strategic investments in a multitude of high-quality cash flowing assets across an array of businesses in the cannabis sector, primarily in U.S. limited license states.
- Motley Fool•6 days ago
Better Buy: Medical Marijuana vs. CV Sciences
Two hemp stocks. One clear winner.
- GlobeNewswire•11 days ago
CV Sciences, Inc. Engages ICR to Enhance Investor Relations and Corporate Communications
LAS VEGAS, Feb. 05, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products.
- ACCESSWIRE•17 days ago
Cannabis Plays in the News
HENDERSON, NV / ACCESSWIRE / January 30, 2019 / As major news is a catalyst for stocks to trend upward, we decided to highlight a few cannabis stocks in the news recently that could be on the verge of ...
- ACCESSWIRE•18 days ago
4 Marijuana Stocks Stepping Up Their Game
CORAL GABLES, FL / ACCESSWIRE / January 29, 2019 / The marijuana stock market has exploded with excitement over the past few weeks, and we've barely reached the one-month mark for the new year. Over time, ...
- ACCESSWIRE•18 days ago
Stocks to Watch This Week
HENDERSON, NV / ACCESSWIRE / January 29, 2019 / Below are a few of the best opportunities on the market this week. One that may want to look at right away is, Gopher Protocol Inc. (GOPH) , an Internet ...
- GlobeNewswire•18 days ago
CBD Gummies In High Demand; International Spirits and Beverage Group (OTC: ISBG), Invictus MD Strategies, CV Sciences and Canopy Growth
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, releases a snapshot focused on the CBD edibles market and how, specifically, CBD gummies are in high demand. Building on that, Transparency Market Research expects the global market for gummy vitamins to rise at a steady CAGR of 5.2% during the period between 2017 and 2025. Last November, Canopy Growth Corporation (NYSE:CGC) (TSX:WEED.TO) started selling CBD-dominant softgels through its Tweed brand, containing 20 milligrams of CBD, and between 2.5 or 10 milligrams of THC.
- ACCESSWIRE•24 days ago
4 Healthcare Stocks To Watch On Wednesday (1/23/19)
With the sheer amount of buzz surrounding the healthcare sector, it stands to reason that companies looking to design and try new approaches to traditional care offerings, such as combining the complex medical applications of cannabis with integrative healthcare frameworks, could create potential opportunities. Premier Health Group (PHGRF) (PHGI), CV Sciences Inc (CVSI), Castlight Health Inc (CSLT), and Aphria Inc (APHA) (APHA) are four healthcare companies determined to pioneer the best quality treatments and products for consumers. Premier Health Group (PHGRF) (PHGI) is a company focused on redesigning how medical care is received and implementing nuanced practical applications for cannabis products in the healthcare space.
- ACCESSWIRE•25 days ago
Watch These 4 Marijuana Stocks Test Their Limits On Tuesday (1/22/19)
As we enter the closing weeks of January, Premier Health Group (PHGRF) (PHGI), HEXO Corp (OTC PINK: HYYDF), GrowGeneration Corp (GRWG), and CV Sciences Inc (CVSI) are four pot stocks representing companies keeping up with their fast-paced industry. Premier Health Group (PHGRF) (PHGI) is a company focused on redesigning how medical care is received and implementing nuanced practical applications for cannabis products in the healthcare space. Recently, the Company has seen impressive growth over the course of the month of January, while simultaneously garnering significant support from the public as well as investors in the cannabis sector.
- GlobeNewswire•25 days ago
CV Sciences, Inc. Announces the Retirement of Its Founder and Management Restructure
CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that Michael Mona, Jr., the Company’s Founder and former President and Chief Executive Officer, has retired from his position as an employee with the Company. The Company also announced that it has eliminated the title of President, and Michael Mona III, will continue as the Company’s Co-Founder and Chief Operating Officer.
- Motley Fool•last month
These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year
Repeat performances could be in store for these big marijuana winners from last year.
- GlobeNewswire•last month
CV Sciences, Inc. Appoints New Chief Accounting Officer
LAS VEGAS, Jan. 08, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp CBD products through its.
- GlobeNewswire•last month
CV Sciences, Inc. to Present at the 21st Annual ICR Conference
LAS VEGAS, Jan. 07, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry-dominating brand of hemp CBD products, PlusCBD Oil™, today.
- GlobeNewswire•last month
CV Sciences, Inc. Named One of the First U.S. Hemp Authority™ Certified Manufacturers
LAS VEGAS, Jan. 03, 2019 -- CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp CBD products through its.
- ACCESSWIRE•2 months ago
CBD and Hemp Plays Positioned for a Big Year
HENDERSON, NV / ACCESSWIRE / December 27, 2018 / After some selling at the end of the year, the cannabis sector looks prime for a major rally.Here are a few securities in the industry that look particularly ...
- ACCESSWIRE•2 months ago
These 4 Marijuana Stocks Are Raising Eyebrows
CORAL GABLES, FL/ ACCESSWIRE / December 26, 2018 / While all other sectors of the market are concerned with high volatility, the cannabis industry has enjoyed positive gains as a result of recent legislation passed that will allow producers to ramp up production to meet the needs of consumers in the space. Premier Health Group (PHGRF) (PHGI), MariMed Inc (MRMD), New Age Beverages Corp (NBEV), and CV Sciences, Inc (CVSI) are 4 pot stocks to pay attention to as we approach the new year. Premier Health Group (PHGRF) (PHGI) saw its company shares enjoy a 2.87% boost in midday trading on Wednesday afternoon, trading at $0.64 per share, up from $0.53 at the end of October and $0.59 on December 9.
- ACCESSWIRE•2 months ago
4 Pharma Stocks Getting a Boost on Thursday (12/20/18)
CORAL GABLES, FL / ACCESSWIRE / December 20, 2018 / The healthcare industry is complicated, this much is certain, but amidst the complexities exist innovative approaches to healthcare that will ultimately provide the best quality of care for patients in the future. From advancements in the nascent telehealth industry to improved treatment options for patients, the healthcare sector may offer significant opportunities in the near future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aevi Genomic Medicine, Inc (GNMX), Aurinia Pharmaceuticals, Inc (AUPH), and CV Sciences, Inc (CVSI) are 4 pharma stocks to pay attention to heading into the rest of the week.
- IPO-Edge.com•2 months ago
Level Brands CEO: Farm Bill Will Prompt Big Retailers to Embrace CBD Products
Martin Sumichrast, CEO of Level Brands, which Plans to Acquire cbdMD By John Jannarone With the passing of the Farm Bill Thursday, major U.S. retailers are likely to pounce on the opportunity to stock their shelves with CBD products after waiting years for such legal clarity. That’s according Level Brands CEO Martin Sumichrast, whose company […]
- GlobeNewswire•2 months ago
CV Sciences, Inc. to Present at Biotech Showcase™ Investor Conference on January 7th in San Francisco
The Company’s executive team to meet with investors at one of industry’s largest annual healthcare conferences LAS VEGAS, Dec. 20, 2018 -- CV Sciences, Inc. (OTCQB: CVSI).
- ACCESSWIRE•2 months ago
Farm Bill, Trump’s Comments, and Cuomo’s Move Make Cannabis Red Hot
HENDERSON, NV / ACCESSWIRE / December 20, 2018 / December has been a big month for cannabis. First, the House and Senate passed the Farm Bill which will make hemp legal federally. Then, Trump commented ...
- GlobeNewswire•2 months ago
CV Sciences, Inc. Featured as a Panelist at 2nd Annual Neuroscience Innovation Forum in San Francisco
Forum to cover partnerships, industry keynotes and influential medical panels LAS VEGAS, Dec. 19, 2018 -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and.
- Benzinga•2 months ago
U.S. Hemp CBD Market to Triple by 2022
The 2018 Farm Bill will restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years. With the removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. New Frontier Data’s Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (or 3.3x) by 2022, representing a 27.2% 5-year CAGR.
- Benzinga•2 months ago
Farm Bill Effect: Impact on U.S. and Global Hemp Markets
Pending President Trump’s signature next week, the 2018 Farm Bill is poised to restore industrial hemp to nationwide legal production for the first time since World War II, offering vast opportunities for the industry and investment in a market expected to triple in four years. With removal of hemp from federal prohibition under the Controlled Substances Act of 1970 (CSA), the total U.S. hemp industry now looks to expand at a healthy 18.4% through a 5-year combined annual growth rate (CAGR) from 2018-2022. Hemp Business Journal estimates that, in leading all hemp product categories, the hemp-derived CBD market will grow from a $390 million-dollar market in 2018, to a $1.3 billion market (3.3x) by 2022, representing a 27.2% 5-year CAGR.
- ACCESSWIRE•2 months ago
President Likely to End Marijuana Ban, These Stocks Could Benefit
HENDERSON, NV / ACCESSWIRE / December 17, 2018 / Recently, he LA Times reported that President Trump declared he would "likely" support a congressional effort to end the federal ban on pot. The move would signify a significant change in the legal cannabis industry, as well as end the threat of a Justice Department crackdown. Today we are highlighting: CleanSpark, Inc. (CLSK), Aphria, Inc. (APHA), Aurora Cannabis, Inc. (ACB), CV Sciences, Inc. (CVSI), and Alliant Energy Corporation (LNT).
